Dr. Sabina Signoretti, MD

Dr. Signoretti practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Signoretti's NPI, 1629510995, was assigned on November 17, 2016. Dr. Signoretti graduated from Sapienza University of Rome in 1988. Dr. Signoretti's Massachusetts license number on file is 272890.

Dr. Signoretti's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Signoretti's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Signoretti is also affiliated with Massachusetts General Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Signoretti to 3 more hospitals and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Signoretti practices, 6 sites in all. Vendor and product names are available with a free account.

Molecular genetic pathology is Dr. Signoretti's primary specialty in the NPI Registry, under taxonomy code 207ZP0007X. Dr. Signoretti is board certified in clinical molecular genetics and genomics by the American Board of Medical Genetics and Genomics. Dr. Signoretti has a license on file in Massachusetts.

CMS data shows 265 Medicare services from Dr. Signoretti across 2 procedure codes in 2024, for 144 Medicare patients. Medicare paid $7,875 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 144 Medicare patients who saw Dr. Signoretti in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Signoretti's median patient age at 62, with 53% women.

Dr. Signoretti accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 178 papers to Dr. Signoretti, published from 2005 to 2025. 2016 was the busiest year, with 9. The most frequent topics are Carcinoma, Renal Cell, Kidney Neoplasms and Biomarkers, Tumor. Dr. Signoretti has published most often in Clin Cancer Res. Dr. Signoretti's most frequent co-authors are Toni K. Choueiri, MD, Michael B. Atkins, MD and David Francis McDermott, MD.

CMS Open Payments shows 12 general payments to Dr. Signoretti from 3 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 98% of the total. AstraZeneca Pharmaceuticals LP paid the most, $32,299.

Dr. Signoretti graduated from Sapienza University of Rome in 1988.

Dr. Signoretti is in network with 4 carriers, including Excellus BlueCross BlueShield, CMS Medicare and RI State Medicaid. Medicaid plans come from the most carriers, 2. Check the plan with the practice before a visit.